Influence of Zika Virus in mechanisms related of cytotoxicity, cell adhesion, apoptosis and inflammatory markers on glioblastoma cells

Glioblastoma (GBM) is one of the most common brain tumors in adults. Despite the presence of available treatments, it remains one of the most lethal and difficult tumors to treat such that most patients die within two years. Studies reported that infection with Zika virus (ZIKV) causes inhibition of cell proliferation as well as induction of apoptosis; moreover, these manifestations show a predilection for developing neuronal cells. In the present study, two GBM cell lines U-138 and U-251 were infected with ZIKV at multiplicities of infection (MOI) 0.1, 0,01 and 0.001 and tested for cell viability, cell migration, cell adhesion, induction of apoptosis, interleukin levels, and cell surface markers (CD14 and CD73). Our study demonstrated that the ZIKV infection promotes loss of cell viability and increased apoptosis potential. It was not evidenced changes in cell migration, however, the two glioblastoma cell lines displayed increased the cell adhesion behavior. There was small increase in the IL-4 level in the U-251 cell line after exposure to ZIKV, with no change in relation to INF-γ levels. Furthermore, we observed an increase in the percentage of cells expressing the CD14 surface marker in both cell lines and increased CD73 expression in the U-251 cell line. Our results suggest that ZIKV may be associated with decrease of cell viability and increased CD73 expression, enhanced adherence, as well as increased apoptosis rates. Further investigations are required to explore the potential use of ZIKV in the treatment of GBM.

[1]  F. Figueiró,et al.  CD73 Downregulation Decreases In Vitro and In Vivo Glioblastoma Growth , 2018, Molecular Neurobiology.

[2]  M. Zatz,et al.  Zika Virus Selectively Kills Aggressive Human Embryonal CNS Tumor Cells In Vitro and In Vivo. , 2018, Cancer research.

[3]  J. Kuo,et al.  Zika Virus has Oncolytic Activity Against Glioblastoma Stem Cells. , 2018, Neurosurgery.

[4]  Qipeng Zhang,et al.  Zika virus infected primary microglia impairs NPCs proliferation and differentiation. , 2018, Biochemical and biophysical research communications.

[5]  William L. Poehlman,et al.  Discovery and validation of a glioblastoma co-expressed gene module , 2018, Oncotarget.

[6]  M. Sughrue,et al.  Glioblastoma: new therapeutic strategies to address cellular and genomic complexity , 2015, Oncotarget.

[7]  S. Weaver,et al.  Functional Analysis of Glycosylation of Zika Virus Envelope Protein. , 2017, Cell reports.

[8]  E. Chiocca,et al.  Oncolytic Viruses in Cancer Treatment: A Review , 2017, JAMA oncology.

[9]  N. Maitland,et al.  The immunosuppressive cytokine interleukin-4 increases the clonogenic potential of prostate stem-like cells by activation of STAT6 signalling , 2017, Oncogenesis.

[10]  Milos Nikolic,et al.  Recent Zika Virus Isolates Induce Premature Differentiation of Neural Progenitors in Human Brain Organoids. , 2017, Cell stem cell.

[11]  D. Sahoo,et al.  CD14-expressing cancer cells establish the inflammatory and proliferative tumor microenvironment in bladder cancer , 2015, Proceedings of the National Academy of Sciences.

[12]  G. Yegutkin Enzymes involved in metabolism of extracellular nucleotides and nucleosides: Functional implications and measurement of activities , 2014, Critical reviews in biochemistry and molecular biology.

[13]  D. Bonatto,et al.  Reviewing and updating the major molecular markers for stem cells. , 2013, Stem cells and development.

[14]  K. Aihara,et al.  Identifying viral parameters from in vitro cell cultures , 2012, Front. Microbio..

[15]  E. Braganhol,et al.  Involvement of ecto-5′-nucleotidase/CD73 in U138MG glioma cell adhesion , 2011, Molecular and Cellular Biochemistry.

[16]  P. Friedl,et al.  The Journal of Cell Biology , 2002 .

[17]  I. Yang,et al.  Interferon-gamma in brain tumor immunotherapy. , 2010, Neurosurgery clinics of North America.

[18]  Amanda Y. Chan,et al.  Cell migration and invasion assays. , 2005, Methods.

[19]  Martin J. van den Bent,et al.  Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.

[20]  P. Ferrara,et al.  Soluble CD14 acts as a negative regulator of human T cell activation and function , 1999, European Journal of Immunology.